texas oncology more breakthroughs. more victories
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

Borghaei and Gunuganti Break Down the Elements of Treatment Selection in NSCLC

Publication: OncLive

In an exclusive podcast interview with OncLive On Air, Vijay Gunuganti, M.D., hematologist and medical oncologist at Texas Oncology–San Antonio Northeast, discusses current frontline treatment options in advanced, driver-negative non–small cell lung cancer. He also details the patient selection process for frontline immunotherapy, combination immunotherapy, and chemoimmunotherapy in non-small cell lung cancer.

Listen to the podcast and view the full story at OncLive.

Related Physicians

Related Cancer Centers